Clinical Trials Related to Hematological Malignancies

Related studies linked through entity extraction aliases.

Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

Status: UNKNOWN
Phase: N/A

B-Cell Hematologic Malignancy Vaccination Registry

Status: WITHDRAWN
Phase: N/A

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Status: RECRUITING
Phase: N/A

Pasireotide in Prevention of GI Toxicity

Status: COMPLETED
Phase: PHASE2

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

Status: UNKNOWN
Phase: N/A

The Good Patient Study

Status: COMPLETED
Phase: N/A

Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

Status: TERMINATED
Phase: PHASE2

PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

Status: TERMINATED
Phase: PHASE2

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

Status: COMPLETED
Phase: NA

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Status: COMPLETED
Phase: PHASE1

Cologne Cohort of Neutropenic Patients (CoCoNut)

Status: RECRUITING
Phase: N/A

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Status: TERMINATED
Phase: PHASE3

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Status: COMPLETED
Phase: PHASE1

Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant

Status: COMPLETED
Phase: PHASE1

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Status: COMPLETED
Phase: PHASE1

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Status: COMPLETED
Phase: PHASE2

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Status: COMPLETED
Phase: PHASE2

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Status: COMPLETED
Phase: PHASE2